Susan E. Bates, MD

Medical Oncology
Specialties
Internal Medicine, Medical Oncology, more

Locations and Appointments


CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue
Floor 9
New York, NY 10032
US
New Patients
Existing Patients
Existing Patients
Login or sign-upto Connect Patient Portal
Existing Patients
Login to Connect Patient Portal make an appointment, view documentation or contact your doctor’s office.
Columbia Connect App
The Columbia Connect app allows you to access convenient services to help manage your health. Access the patient portal, communicate with your doctor, manage appointments, view test results, request prescription refills, pay a bill, and find a doctor.

Second Opinion

Our specialists are ready to provide you with a second opinion. Learn more about second opinions or click to start your online second opinion.
Get a Second Opinion

Insurances Accepted


Please contact the doctor's office directly to verify that your particular insurance is accepted.

    Aetna Signature Administrators
    EPO
    PPO
    HMO
    NY Signature
    Student Health
    POS
    NYP Employee Plan
    Medicare Managed Care
    Medicaid Managed Care
    Essential Plan
    Special Needs
    Medicare Managed Care
    Special Needs
    PPO
    POS
    Great West (National)
    HMO
    Medicare Managed Care
    EPO
    PPO
    Medicare Managed Care
    HMO
    PPO
    Vytra
    Medicaid Managed Care
    EPO
    Select Care (Exchange)
    ConnectiCare
    POS
    Essential Plan
    Medicare Managed Care
    Essential Plan
    Medicaid Managed Care
    Child/Family Health Plus
    EPO
    PPO
    HMO
    Local 32BJ
    Medicare Managed Care
    Medicaid Managed Care
    Medicare Managed Care
    Child/Family Health Plus
    Essential Plan
    Medicaid Managed Care
    Medicare Managed Care
    Child/Family Health Plus
    Leaf (Exchange)
    Local 1199
    MagnaCare
    Railroad
    Traditional Medicare
    Multiplan
    Child/Family Health Plus
    HMO
    Essential Plan
    Medicaid Managed Care
    Quality Health Management
    Special Needs
    Compass (Exchange)
    HMO
    POS
    PPO
    Medicare Managed Care
    Empire Plan
    Medicaid (Community Plan)
    Oxford Freedom
    Oxford HMO
    Oxford Liberty
    SelectHealth
    Medicare Managed Care
    Special Needs
    Medicaid Managed Care
    Medicare Managed Care
    World Trade Center Health Plan
    Aetna Signature Administrators
    EPO
    PPO
    HMO
    NY Signature
    Student Health
    POS
    NYP Employee Plan
    Medicare Managed Care
    Medicaid Managed Care
    Essential Plan
    Special Needs
    Medicare Managed Care
    Special Needs
    PPO
    POS
    Great West (National)
    HMO
    Medicare Managed Care
    EPO
    PPO
    Medicare Managed Care
    HMO
    PPO
    Vytra
    Medicaid Managed Care
    EPO
    Select Care (Exchange)
    ConnectiCare
    POS
    Essential Plan
    Medicare Managed Care
    Essential Plan
    Medicaid Managed Care
    Child/Family Health Plus
    EPO
    PPO
    HMO
    Local 32BJ
    Medicare Managed Care
    Medicaid Managed Care
    Medicare Managed Care
    Child/Family Health Plus
    Essential Plan
    Medicaid Managed Care
    Medicare Managed Care
    Child/Family Health Plus
    Leaf (Exchange)
    Local 1199
    MagnaCare
    Railroad
    Traditional Medicare
    Multiplan
    Child/Family Health Plus
    HMO
    Essential Plan
    Medicaid Managed Care
    Quality Health Management
    Special Needs
    Compass (Exchange)
    HMO
    POS
    PPO
    Medicare Managed Care
    Empire Plan
    Medicaid (Community Plan)
    Oxford Freedom
    Oxford HMO
    Oxford Liberty
    SelectHealth
    Medicare Managed Care
    Special Needs
    Medicaid Managed Care
    Medicare Managed Care
    World Trade Center Health Plan

About Susan E. Bates, MD


Dr. Susan Bates received her M.D. degree from the University of Arkansas School of Medicine. She completed her clinical training in internal medicine at Georgetown University in Washington, D.C., and in medical oncology at the National Cancer Institute (NCI) in Bethesda, MD. Dr. Bates was a Lead Clinical Investigator and Head of the Molecular Therapeutics Section in the Developmental Therapeutics Branch of the Center for Cancer Research before moving to Columbia University in August 2015.


During her years at the NCI, Dr. Bates led a highly successful translational research program focused on mechanisms of multidrug resistance and approaches to evaluate and improve the activity of epigenetic modifying agents. Her laboratory was among the first to clone the multidrug transporter ABCG2, eventually characterizing its function and its role in chemo-resistance and chemo-protection. This effort built upon earlier work elaborating the role of the multi-drug transporter P-glycoprotein that had defined the drug sensitivity profiles of cell lines in vitro, particularly in the NCI-60 cell line panel. The latter observation continues to impact how the NCI-60 cell line panel is used in drug discovery, and helped her identify a novel agent, at that time known as depsipeptide. Dr. Bates brought this drug to the clinic and after completing its phase I testing, served as Principal Investigator of a multi-institutional, international Phase II study of romidepsin (depsipeptide) in cutaneous and peripheral T-cell lymphoma. Working with Gloucester Pharmaceuticals, the data from this study were included in New Drug Applications (NDA) to the U.S. Food & Drug Administration (FDA). This partnership led to approval by the FDA of romidepsin for two indications - initially for cutaneous T-cell lymphoma and later for peripheral T-cell lymphoma.


Dr. Bates' current interests are both laboratory and clinical in nature. Her laboratory efforts include laboratory and translational studies on drug resistance in T-cell lymphomas and advanced solid tumors including breast, pancreatic, neuroendocrine, renal and lung cancers. Her work is dedicated to new drug development, and finding antineoplastic agents that, alone or in combination with other anticancer agents, improve the options available for difficult to treat cancers. Emanating from the clinical and translational development of romidepsin, a histone deacetylase (HDAC) inhibitor, a current focus is on epigenetic therapies, and the development of combination therapies to use with HDAC inhibitors in refractory advanced cancers, including solid tumors. She also has a special interest in drug delivery and drug distribution and the role of the blood brain barrier in creating a sanctuary site for cancers that metastasize to the brain. Clinically, her goal has always been to translate ideas from the laboratory to clinical trials, an effort that has proven very successful. Clinically she seeks to develop combination therapies with histone deacetylase inhibitors for the therapy of solid tumors; and to develop therapies to treat central nervous system metastases, a complication of cancer that is becoming a greater problem as patients live longer with cancer.


Board Certifications

  • Internal Medicine
  • Medical Oncology

Specialties & Expertise

  • Brain Metastases
  • Chemotherapy
  • Gallbladder Cancer
  • Liver Cancer
  • Oncology
  • Pancreatic Cancer
  • T-Cell Lymphoma

Education

  • Fellowship: National Cancer Institute
  • Residency: Georgetown University Medical Center
  • Residency: University of Arkansas Medical Center

Leadership, Titles & Positions

  • Director, Translational Cancer Medicine
  • Professor of Medicine at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Need Help Finding a Doctor?